Vaccinex, Inc. Deferred Offering Costs
Vaccinex, Inc. (VCNX) had Deferred Offering Costs of $0 as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2022-03-31
- 2021-12-31: Deferred Offering Costs $0.00.
- 2021-03-31: Deferred Offering Costs $0.00.
- 2020-12-31: Deferred Offering Costs $0.00.
- 2020-09-30: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-31 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-13 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
| 2018-06-30 | $1.73M 10-Q · filed 2018-08-14 |